SCHEMBL29899286

SCHEMBL29899286

CC1(c2ccon2)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15326800 0.91 — —
SCHEMBL29899245 0.79 BACE1 (0.33) —
SCHEMBL28302332 0.73 MKNK1 (0.30) —
SCHEMBL28322626 0.69 SLC6A4 (0.33) —
SCHEMBL22395018 0.69 OPRM1 (0.33) —
SCHEMBL29899246 0.65 — —
SCHEMBL15321983 0.65 MBOAT4 (0.31) —
SCHEMBL30320626 0.65 CHRM1 (0.31) —
SCHEMBL573556 0.64 KDM4E (0.33) —
SCHEMBL14844386 0.64 HDAC4 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250257056-A1 ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2025-08-14 — — US disclosed
US-12319672-B2 Alpha-D-galactopyranoside derivatives IDORSIA PHARMACEUTICALS LTD (CH) 2025-06-03 — — US disclosed
US-20220281855-A1 ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2022-09-08 — — US disclosed
Send feedback